DSpace at RU >

Search Results

Results 1-17 of 17.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2007	Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrence.	Schultz, I.J.; Kok, J.B. de; Witjes, J.A.; Babjuk, M.; Willems, J.L.; Wester, K.; Swinkels, D.W.; Tjalsma, H.
	2007	The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinoma.	Schultz, I.J.; Kiemeney, L.A.L.M.; Roelofs, R.; Aarssen, Y. van; Babjuk, M.; Willems, J.L.; Malmstrom, P.U.; Swinkels, D.W.; Witjes, J.A.; Kok, J.B. de
	2007	Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma.	Schultz, I.J.; Wester, K.; Straatman, H.M.P.M.; Kiemeney, L.A.L.M.; Babjuk, M.; Mares, J.; Willems, J.L.; Swinkels, D.W.; Witjes, J.A.; Malmstrom, P.U.; Kok, J.B. de
	2006	Valkuil bij een verworven Pelger Huët.	Meer, W. van der; Koster-Kamphuis, L.; Kok, J.B. de
	2006	Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.	Schultz, I.J.; Kiemeney, L.A.L.M.; Willems, J.L.; Swinkels, D.W.; Witjes, J.A.; Kok, J.B. de
	2006	Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin.	Schultz, I.J.; Witjes, J.A.; Swinkels, D.W.; Kok, J.B. de
	2006	Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation study.	Schultz, I.J.; Wester, K.; Straatman, H.M.P.M.; Kiemeney, L.A.L.M.; Babjuk, M.; Mares, J.; Willems, J.L.; Swinkels, D.W.; Witjes, J.A.; Kok, J.B. de; Malmstrom, P.U.
	2006	Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?	Span, P.N.; Tjan-Heijnen, V.C.; Heuvel, J.J.T.M.; Kok, J.B. de; Foekens, J.A.; Sweep, C.G.J.
	2005	CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas.	Schultz, I.J.; Kiemeney, L.A.L.M.; Witjes, J.A.; Schalken, J.A.; Willems, J.L.; Swinkels, D.W.; Kok, J.B. de
	2005	Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes.	Kok, J.B. de; Roelofs, R.W.; Giesendorf, B.A.J.; Pennings, J.L.; Waas, E.T.; Feuth, A.B.; Swinkels, D.W.; Span, P.N.
	2004	Foetaal DNA in maternaal bloed.	Swinkels, D.W.; Kok, J.B. de; Steegers, E.A.P.
	2004	Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.	Schultz, I.J.; Kiemeney, L.A.L.M.; Karthaus, H.F.M.; Witjes, J.A.; Willems, J.L.; Swinkels, D.W.; Klein Gunnewiek, J.M.T.; Kok, J.B. de
	2004	Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk.	Logt, E.M.J. van der; Bergevoet, S.M.; Roelofs, H.M.J.; Hooijdonk, Z. van; Morsche, R.H.M. te; Wobbes, Th.; Kok, J.B. de; Nagengast, F.M.; Peters, W.H.M.
	2004	Survivin is an independent prognostic marker for risk stratification of breast cancer patients.	Span, P.N.; Sweep, C.G.J.; Wiegerinck, E.T.G.; Tjan-Heijnen, V.C.; Manders, P.; Beex, L.V.A.M.; Kok, J.B. de
	2000	Molecular tumor-diagnostics in body fluids	Kok, Jacques Benno de
	1997	Detection of tumor DNA in serum of colorectal cancer patients	Kok, J.B. de; Solinge, W.W. van; Ruers, T.J.M.; Roelofs, R.H.W.M.; Muijen, G.N.P. van; Willems, J.L.; Swinkels, D.W.
	1996	Ras-oncogene detection of faeces of patients with colorectal tumors	Swinkels, D.W.; Kok, J.B. de; Muijen, G.N.P. van; Willems, J.L.

1